Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.

Saved in:
Bibliographic Details
Title: Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD.
Authors: Sadigh G; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, United States of America. Electronic address: gsadigh@uci.edu., Duan F; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Gareen IF; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America; Brown University School of Public Health Department of Epidemiology, Providence, RI, United States of America., Hancock J; Cancer Research for the Ozarks NCORP, Springfield, MO, United States of America., Sicks JD; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Thangarajah M; Brown University - ECOG-ACRIN Biostatistics Center, Providence, RI, United States of America., Meisel JL; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America., Torres MA; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America., Ramsey SD; Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, United States of America., Wolff AC; Sidney Kimmel Cancer Center, John Hopkins University, MD, United States of America., Wagner LI; University of North Carolina at Chapel Hill, NC, United States of America., Carlos RC; Columbia University, New York, NY, United States of America., Graetz I; Winship Cancer Institute, Emory University, Atlanta, GA, United States of America.
Source: Contemporary clinical trials [Contemp Clin Trials] 2026 Jan; Vol. 160, pp. 108145. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1559-2030
DOI:10.1016/j.cct.2025.108145